Case Law & Settlements

Billed-vs-Paid Medical Liens Still Rule as Appellate Calendar Goes Quiet

No dated appellate or MDL ruling with a caption and dollar figure cleared verification for 11/14-11/20.

Billed-vs-Paid Medical Liens Still Rule as Appellate Calendar Goes Quiet

No dated appellate or MDL ruling with a caption and dollar figure cleared verification for 11/14-11/20. California's billed-vs-paid lien framework, including the $1,063 judgment modification in Pebley, remains the operative law while two mass torts hit filing deadlines instead of rulings.

No Marquee Verdict This Week, But the Lien Fight Didn't Take a Break

A review of appellate dockets, MDL trackers, and state court records for the week of November 14 through November 20 turned up no dated ruling carrying both a verified caption and a dollar figure. For firms hoping to cite a fresh blockbuster in a demand letter this week, there isn't one.

That gap matters less than it sounds. The framework governing medical damages in the nation's largest plaintiff PI market, California's billed-versus-paid line of cases, remains contested enough at the margins that trial courts relitigate it weekly without any new published opinion forcing the issue.

For medical providers treating PI patients on a lien, the live question hasn't changed: does a client's decision to forgo insurance and treat on a lien convert them into an uninsured patient for damages purposes. That question is answered by case law now eight years old, not by anything filed this month.

Also on this week's docket: a California fee-after-termination ruling, a Florida Daubert exclusion the bar keeps citing without a confirmed 2026 date, and two mass-tort trackers reporting deadlines rather than decisions.

Counsel waiting on new precedent this week should instead audit their own lien files against the existing Pebley framework before a defense motion forces the issue.

Pebley and Howell Still Set the Billed-vs-Paid Baseline

Pebley v. Santa Clara Organics, LLC, 22 Cal.App.5th 1266 (2d Dist., Div. 6, 2018), remains the controlling template. A plaintiff with insurance elected to treat on a lien instead, and the court held that election treats her as uninsured for damages purposes, making the full billed lien amount admissible rather than the lower negotiated rate.

The appellate panel modified the judgment downward by $1,063 to correct one damages component, but left the core holding intact: lien-based treatment preserves the sticker rate as evidence.

Howell v. Hamilton Meats & Provisions (Cal. 2011) sits on the other side of that line, capping past medical damages at amounts actually paid or accepted as payment in full when a plaintiff uses insurance. The two rulings coexist only because the triggering fact, insurance use versus lien election, differs.

For providers evaluating whether to accept PI liens through a directory relationship, Pebley is the backstop that keeps the billed rate as the evidentiary ceiling, provided the patient genuinely proceeds outside coverage rather than simply delaying a claim submission.

Any intake file where a client has active coverage but signs a lien still needs a documented election-not-to-use-insurance record before trial.

The Qaadir/Ochoa Split Keeps Defense Counsel Guessing

Qaadir v. Figueroa (2021) followed Pebley's reasoning and expressly declined to follow Ochoa v. Dorado, a divergence commentators have described as a split of authority running across California's appellate districts.

The petition for review in Pebley, docketed as S249399, does not have a confirmed disposition in the sources checked this week. Counsel relying on Pebley as settled law should pull the current Supreme Court docket rather than citing secondary summaries.

What this means operationally: in districts where Qaadir-style reasoning controls, lien-based billing at full rate survives defense challenges. In districts leaning toward Ochoa's narrower reading, defense teams will keep moving to cap recoveries at paid amounts even where the plaintiff treated on a lien in good faith.

Case managers filing in multiple counties need a jurisdiction-by-jurisdiction cheat sheet on which line of authority their local Court of Appeal division has actually applied, not just a statewide assumption that Pebley settled the question.

Firms with venue flexibility should factor the Ochoa/Qaadir split into forum selection before locking in a lien-based treatment plan.

Two Mass Torts Hit Deadlines, Not Rulings

In the hair relaxer MDL 3060, summary judgment and non-general-causation Daubert motions were due November 16, 2026, according to a litigation tracker. That is a filing deadline, not an order, and any substantive ruling on those motions remains pending.

In the Depo-Provera MDL 3140, the Daubert hearing has been moved to September 18, 2026. One secondary tracker also reports a settlement already signed and 6,413 cases pending per the November 2026 JPML report, but neither figure was independently confirmed against the JPML docket in this week's research pass.

Firms with inventory in either MDL should treat tracker blog posts as a starting point for internal docket monitoring, not as something to repeat to a client or adjuster without pulling the underlying court filing.

Bellwether exposure in both dockets will turn on how the pending Daubert motions land, and that outcome is still months out in both cases.

Any client communication referencing a Depo-Provera settlement figure this week is getting ahead of a docket that has not confirmed one.

Fee Disputes After Termination Stay a Live Wire

Chong v. Mardirossian & Akaragian, decided by a California Court of Appeal on January 8, 2026, addressed what a discharged firm may recover in fees after being terminated mid-representation, a recurring flashpoint as referral-driven PI practices scale.

The question of quantum meruit recovery versus a full contingency percentage keeps resurfacing as more firms build case volume through co-counsel and referral arrangements rather than direct intake, multiplying the number of mid-case handoffs that end in a fee dispute.

For firm operators, the practical lesson is procedural: engagement letters and referral agreements need explicit termination-fee language now, because appellate courts are still filling in gaps that boilerplate contracts leave open.

Paralegals tracking receivables on referred cases should flag any file where representation changed hands, since those are the files most likely to generate a post-settlement fee motion.

Every referral-fee agreement signed this quarter should specify what happens to the percentage if the referring firm is terminated before resolution.

Florida's Daubert Line Holds, Pending a Confirmed Date

Williams v. Leesburg Regional Medical Center, decided by Florida's Fifth District Court of Appeal, affirmed the exclusion of a plaintiff's experts under the state's Daubert standard. The exact 2026 decision date was not confirmed in available sources and likely predates this week's search window.

Counsel should hold off citing it as a November 2026 ruling until the official reporter date is verified, but the substantive holding on expert reliability continues to control causation disputes in Florida PI and medical-malpractice-adjacent claims.

For providers and treating physicians asked to serve as experts in Florida PI cases, the exclusion standard underscores the documentation bar: opinions tied loosely to the medical record are increasingly vulnerable regardless of credentials.

Across the three states tracked this week, zero verified dollar-figure rulings cleared confirmation, leaving counsel to work from existing precedent until the next published opinion lands.

Florida counsel relying on Williams for an expert-exclusion argument should confirm the reporter citation before filing, not after a defense motion forces the issue.

Who LawyersTrend is for

Three ways in

Selling to the PI bar? See sponsor and advertiser options.